Dolby Laboratories Inc (DLB)
NYSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current DLB market cap is 7.49B. The company's latest EPS is USD 2.7435 and P/E is 28.59.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 290.56M | 315.57M | 364.52M | 288.82M | 304.81M |
| Operating Income | -3.49M | 66.22M | 108.97M | 36.78M | 60.55M |
| Net Income | 9.19M | 66.98M | 97.83M | 38.44M | 58.57M |
| Year End September 26 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.16B | 1.28B | 1.25B | 1.3B | 1.27B |
| Operating Income | 218.74M | 330.52M | 206.61M | 215.75M | 272.53M |
| Net Income | 231.36M | 310.23M | 184.09M | 200.66M | 261.83M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.98B | 2.94B | 3.04B | 2.97B | 3.11B |
| Total Liabilities | 607.58M | 573.22M | 607.04M | 526.2M | 623.04M |
| Total Equity | 2.37B | 2.36B | 2.44B | 2.45B | 2.49B |
| Year End September 26 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.92B | 3.11B | 2.69B | 2.98B | 3.11B |
| Total Liabilities | 478.92M | 501.46M | 438.53M | 607.58M | 623.04M |
| Total Equity | 2.44B | 2.6B | 2.25B | 2.37B | 2.49B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 367.08M | 8.41M | 189.82M | 211.08M | 327.25M |
| Investing | 54.21M | 633k | -17.24M | -24.98M | -286.29M |
| Financing | -236.81M | -125.14M | -169.3M | -227.7M | -287.81M |
| Year End September 26 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 343.85M | 447.75M | 318.58M | 367.08M | 327.25M |
| Investing | 134.37M | -44.91M | -295.94M | 54.21M | -286.29M |
| Financing | -207.78M | -252.52M | -610.56M | -236.81M | -287.81M |
| Market Cap | 7.49B |
| Price to Earnings Ratio | 28.59 |
| Price to Sales Ratio | 5.88 |
| Price to Cash Ratio | 15.53 |
| Price to Book Ratio | 3.01 |
| Dividend Yield | 1.68% |
| Shares Outstanding | 95.44M |
| Average Volume (1 week) | 577.33k |
| Average Volume (1 Month) | 527.23k |
| 52 Week Change | -9.26% |
| 52 Week High | 87.12 |
| 52 Week Low | 66.35 |
| Spread (Intraday) | 0.9 (1.14%) |
| Company Name | Dolby Laboratories Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dolby.com |
| Industry | patent owners and lessors (6794) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
